Answering burning questions on MMR vaccines

Stay informed about health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

Good morning! Beyond just the excitement of concerts, have you ever shared a moment of collective shouting with a massive crowd? Attendees at the recent AAP National Conference had their chance. Let’s dive into some of the pressing news keeping pediatricians on alert.

Could Government Shutdown Happen Tomorrow?

The potential government shutdown looms as Congress faces a deadline. If funding is not secured by the end of tomorrow, patients currently benefiting from hospital-level care at home could be forced back into hospital settings. The Acute Hospital Care at Home initiative, which typically receives funding through government bills, permits Medicare to bypass certain regulations that allow hospitals to treat patients at home. The Centers for Medicare & Medicaid Services (CMS) has indicated that a failure in Congressional action will require that “all inpatients must be discharged or returned to the hospital on September 30, 2025.”

“This scenario could lead to a significant surge of patients needing traditional hospital care,” warns Dr. David Levine from Mass General Brigham, who coordinates hospital-at-home programs. Read more from STAT’s John Wilkerson and Mario Aguilar.

Critical Conversations About MMR Vaccines

In a recent statement, former President Trump called for a reexamination of the measles, mumps, and rubella (MMR) vaccine, suggesting to “BREAK UP THE MMR SHOT INTO THREE TOTALLY SEPARATE SHOTS.” While details of where he derived this concept remain unclear, it’s crucial to note that parents currently have the choice between the combined MMR vaccine or a single shot that includes chickenpox (varicella). Extensive research indicates that separating these vaccines is unlikely to offer any additional health benefits.

More insights from STAT’s Anil Oza delve into the history of monovalent vaccines for each disease, the barriers to reintroduction, and potential effects of separate vaccinations on overall immunization rates.

Cochrane Review Confirms Safety of RSV Vaccines

In a promising development, a recent Cochrane review has affirmed the safety and efficacy of vaccines targeting respiratory syncytial virus (RSV), which poses a significant threat especially to vulnerable populations such as young infants and the elderly. The review analyzed data from 14 randomized controlled trials involving over 113,000 participants.

Earlier this year, health secretary Robert F. Kennedy Jr.’s Advisory Committee on Immunization Practices advocated for the inclusion of a new monoclonal antibody against RSV for infants, but recent discussions raised skepticism about vaccine safety data, hinting at an inclination to revert to previous vaccine standards based on anecdotal concerns rather than empirical evidence. Moreover, with Trump’s recent remarks against vaccines, it becomes evident that Kennedy’s influence is growing.

The Rise of Perimenopause Awareness

Perimenopause, the transitional phase preceding menopause characterized by fluctuating hormone levels, is gaining newfound recognition. After recent increased awareness around menopause — often viewed as overlooked — there is a burgeoning focus on perimenopause, projecting health entrepreneurs to target this $18 billion market with communities, supplements, meal plans, and more.

STAT’s Sarah Todd engaged with women’s health experts who emphasize the importance of the conversation while expressing skepticism towards new products that may not effectively address symptoms such as sleep disturbances, hot flashes, and mood fluctuations, which could stem from various causes. Explore more about the perimenopause product boom and the potential gaps they might help fill in Sarah’s piece here.

Celebrating 25 Years of Mifepristone

Mifepristone, commonly referred to as the “abortion pill,” marks its 25th anniversary of FDA approval this week. In an insightful piece, Elisa Wells, co-founder of Plan C Pills, which assists individuals in obtaining abortion medication across the U.S., reflects upon the revolutionary impact of this drug on reproductive health access.

Read her essay here, particularly important as federal health officials undergo a review concerning the drug’s safety, despite existing studies that affirm its safety and effectiveness, even when delivered by mail.

Launching “Neurotransmissions”: A Column on Dementia

With about 7.2 million Americans living with dementia—a number projected to rise to 13.8 million by 2060—there’s a pressing need to alter the discourse surrounding dementia. Physician Jason Karlawish advocates for a focus on prevalent diseases that lead to dementia, including Alzheimer’s and the relatively unrecognized LATE (limbic-predominant age-related TDP-43 encephalopathy) — potentially one of the most common causes among seniors over 75. Stay tuned for future columns that will bring light to the evolving landscape of dementia. Read more.

What We’re Reading

• Insights into Tylenol’s recent crisis in the Wall Street Journal.

• The NIH’s recent achievements and ongoing challenges in the Washington Post.

• Discussion on public health measures surrounding gun silencers in STAT.

• Anti-vaccine activists staged a rally near where a gunman previously attacked, detailed in Mother Jones.

• Fostering the future of medicine manufacturing through the FDA’s new PreCheck program, insights from Eli Lilly in STAT.